Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
CNY 4.99
(2.25%)
CNY 4.99
(2.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -147.41 Million CNY | -886.87% |
| 2022 | -14.93 Million CNY | 35.16% |
| 2021 | -23.03 Million CNY | -123.49% |
| 2020 | 98.06 Million CNY | 249.6% |
| 2019 | 28.05 Million CNY | -28.53% |
| 2018 | 39.25 Million CNY | -17.54% |
| 2017 | 47.6 Million CNY | -8.42% |
| 2016 | 51.98 Million CNY | 1.44% |
| 2015 | 51.24 Million CNY | -4.0% |
| 2014 | 53.38 Million CNY | 11.11% |
| 2013 | 48.04 Million CNY | 34.33% |
| 2012 | 35.76 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -14.33 Million CNY | -1895.46% |
| 2024 Q1 | 1.74 Million CNY | 101.13% |
| 2024 Q2 | -718.6 Thousand CNY | -141.18% |
| 2023 Q2 | 969.69 Thousand CNY | -86.01% |
| 2023 Q1 | 6.93 Million CNY | 130.69% |
| 2023 FY | -147.41 Million CNY | -886.87% |
| 2023 Q4 | -154.67 Million CNY | -24153.75% |
| 2023 Q3 | -637.75 Thousand CNY | -165.77% |
| 2022 Q3 | 902.07 Thousand CNY | 282.01% |
| 2022 Q2 | 236.14 Thousand CNY | -96.49% |
| 2022 Q1 | 6.72 Million CNY | 117.94% |
| 2022 FY | -14.93 Million CNY | 35.16% |
| 2022 Q4 | -22.58 Million CNY | -2603.79% |
| 2021 Q4 | -37.5 Million CNY | -1164.73% |
| 2021 Q3 | 3.52 Million CNY | 68.65% |
| 2021 Q1 | 9.12 Million CNY | 47.87% |
| 2021 FY | -23.03 Million CNY | -123.49% |
| 2021 Q2 | 2.08 Million CNY | -77.12% |
| 2020 FY | 98.06 Million CNY | 249.6% |
| 2020 Q4 | 6.17 Million CNY | -28.87% |
| 2020 Q1 | 9.43 Million CNY | 282.85% |
| 2020 Q2 | 73.78 Million CNY | 682.19% |
| 2020 Q3 | 8.67 Million CNY | -88.24% |
| 2019 Q3 | 10.13 Million CNY | -26.47% |
| 2019 FY | 28.05 Million CNY | -28.53% |
| 2019 Q4 | -5.15 Million CNY | -150.92% |
| 2019 Q1 | 9.3 Million CNY | 170.18% |
| 2019 Q2 | 13.77 Million CNY | 48.11% |
| 2018 Q3 | 14.05 Million CNY | -46.42% |
| 2018 FY | 39.25 Million CNY | -17.54% |
| 2018 Q4 | -13.25 Million CNY | -194.28% |
| 2018 Q2 | 26.24 Million CNY | 115.01% |
| 2018 Q1 | 12.2 Million CNY | 88.22% |
| 2017 FY | 47.6 Million CNY | -8.42% |
| 2017 Q1 | 11.57 Million CNY | -22.82% |
| 2017 Q2 | 16.24 Million CNY | 40.3% |
| 2017 Q3 | 13.29 Million CNY | -18.2% |
| 2017 Q4 | 6.48 Million CNY | -51.21% |
| 2016 FY | 51.98 Million CNY | 1.44% |
| 2016 Q4 | 15 Million CNY | 37.03% |
| 2016 Q3 | 10.94 Million CNY | -15.87% |
| 2016 Q2 | 13.01 Million CNY | 0.0% |
| 2016 Q1 | 13.01 Million CNY | 0.0% |
| 2015 FY | 51.24 Million CNY | -4.0% |
| 2014 FY | 53.38 Million CNY | 11.11% |
| 2013 FY | 48.04 Million CNY | 34.33% |
| 2012 FY | 35.76 Million CNY | 0.0% |